atovaquone has been researched along with Chronic Illness in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (50.00) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amani, A; Azami, SJ; Faramarzi, MA; Keshavarz, H; Mahmoudi, M; Mohebali, M; Najafi-Taher, R; Shojaee, S | 1 |
Abdel-Aziz, A; Azab, MS; El-Tantawy, NL; Elmehankar, MS; Hegazy, MM | 1 |
Dezube, BJ; Kirby, JE; Konstantinopoulos, PA; Miller, KB | 1 |
Irwin, PJ; Jardine, J; Jefferies, R; Robertson, ID; Ryan, UM | 1 |
Araujo, FG; Ferguson, DJ; Huskinson-Mark, J; Remington, JS | 1 |
Gormley, PD; Lightman, S; Minnasian, D; Pavesio, CE | 1 |
Aumjaud, Y; Derouin, F; Fessi, H; Sordet, F | 1 |
Gray, JS; Pudney, M | 1 |
8 other study(ies) available for atovaquone and Chronic Illness
Article | Year |
---|---|
Nanoemulsion of atovaquone as a promising approach for treatment of acute and chronic toxoplasmosis.
Topics: Acute Disease; Animals; Anti-Infective Agents; Atovaquone; Chronic Disease; Emulsions; Female; Grape Seed Extract; HeLa Cells; Humans; Mice, Inbred BALB C; Nanostructures; Toxoplasma; Toxoplasmosis | 2018 |
Sex dichotomy in the course of experimental latent toxoplasmosis.
Topics: Animals; Antibodies, Protozoan; Atovaquone; Brain; Chronic Disease; Coccidiostats; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Estradiol; Female; Immunoglobulin G; Interleukin-12; Male; Metronidazole; Mice; Morbidity; Sex Factors; Spiramycin; Testosterone Propionate; Toxoplasma; Toxoplasmosis, Animal | 2019 |
Babesiosis masquerading as recurrent immune thrombocytopenic purpura in a splenectomized patient.
Topics: Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antibodies, Protozoan; Antimalarials; Atovaquone; Azithromycin; Babesiosis; Chronic Disease; Erythrocyte Inclusions; False Positive Reactions; Female; Humans; Immunoglobulin G; Immunoglobulin M; Platelet Count; Prednisone; Purpura, Thrombocytopenic, Idiopathic; Splenectomy | 2006 |
Babesia gibsoni: detection during experimental infections and after combined atovaquone and azithromycin therapy.
Topics: Acute Disease; Animals; Anti-Infective Agents; Antibodies, Protozoan; Atovaquone; Azithromycin; Babesia; Babesiosis; Chronic Disease; DNA, Protozoan; Dog Diseases; Dogs; Drug Resistance; Female; Fluorescent Antibody Technique; Parasitemia; Polymerase Chain Reaction | 2007 |
An ultrastructural study of the effect of treatment with atovaquone in brains of mice chronically infected with the ME49 strain of Toxoplasma gondii.
Topics: Animals; Antiprotozoal Agents; Atovaquone; Brain; Chronic Disease; Female; Mice; Mice, Inbred CBA; Microscopy, Electron; Naphthoquinones; Toxoplasmosis, Animal; Toxoplasmosis, Cerebral | 1994 |
Effects of drug therapy on Toxoplasma cysts in an animal model of acute and chronic disease.
Topics: Acute Disease; Animals; Anti-Bacterial Agents; Antiprotozoal Agents; Atovaquone; Brain; Chorioretinitis; Chronic Disease; Cricetinae; Disease Models, Animal; Drug Therapy, Combination; Female; Mesocricetus; Naphthoquinones; Retina; Toxoplasma; Toxoplasmosis, Cerebral; Toxoplasmosis, Ocular | 1998 |
Assessment of the activity of atovaquone-loaded nanocapsules in the treatment of acute and chronic murine toxoplasmosis.
Topics: Acute Disease; Administration, Oral; Animals; Antiprotozoal Agents; Atovaquone; Brain; Capsules; Chronic Disease; Colloids; Disease Models, Animal; Drug Carriers; Drug Stability; Female; Lung; Mice; Naphthoquinones; Parasitemia; Solubility; Survival Rate; Suspensions; Temperature; Toxoplasma; Toxoplasmosis, Animal | 1998 |
Activity of atovaquone against Babesia microti in the Mongolian gerbil, Meriones unguiculatus.
Topics: Acute Disease; Animals; Antiprotozoal Agents; Atovaquone; Babesiosis; Chronic Disease; Clindamycin; Diminazene; Dose-Response Relationship, Drug; Drug Resistance; Drug Therapy, Combination; Gerbillinae; Humans; Imidocarb; Naphthoquinones; Pentamidine; Recurrence | 1999 |